Mymetics MYMX Stock
Mymetics Price Chart
Mymetics MYMX Financial and Trading Overview
| Mymetics stock price | 0.0100 USD |
| Previous Close | 0.009 USD |
| Open | 0.0095 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.009 - 0.0095 USD |
| 52 Week Range | 0.006 - 0.06 USD |
| Volume | 1.1K USD |
| Avg. Volume | 96.67K USD |
| Market Cap | 2.73M USD |
| Beta (5Y Monthly) | 0.198943 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -107.41 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MYMX Valuation Measures
| Enterprise Value | 75.51M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.3339293 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 92.084 |
| Enterprise Value/EBITDA | -41.973 |
Trading Information
Mymetics Stock Price History
| Beta (5Y Monthly) | 0.198943 |
| 52-Week Change | -83.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 USD |
| 52 Week Low | 0.006 USD |
| 50-Day Moving Average | 0.00964 USD |
| 200-Day Moving Average | 0.03 USD |
MYMX Share Statistics
| Avg. Volume (3 month) | 96.67K USD |
| Avg. Daily Volume (10-Days) | 31.09K USD |
| Shares Outstanding | 303.76M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 43.37% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -220.97% |
| Gross Margin | -35.85% |
| EBITDA Margin | -219.39% |
Management Effectiveness
| Return on Assets (ttm) | -15.23% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 820K USD |
| Revenue Per Share (ttm) | 0.003 USD |
| Quarterly Revenue Growth (yoy) | -42.89% |
| Gross Profit (ttm) | 1.03M USD |
| EBITDA | -1799000 USD |
| Net Income Avi to Common (ttm) | -5455000 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 335K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 73.11M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.007 |
| Book Value Per Share (mrq) | -0.22 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1711000 USD |
| Levered Free Cash Flow (ttm) | -2014375 USD |
Profile of Mymetics
| Country | United States |
| State | N/A |
| City | Epalinges |
| Address | BiopOle Center |
| ZIP | 1066 |
| Phone | 41 21 653 4535 |
| Website | https://www.mymetics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 11 |
Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.
Q&A For Mymetics Stock
What is a current MYMX stock price?
Mymetics MYMX stock price today per share is 0.0100 USD.
How to purchase Mymetics stock?
You can buy MYMX shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mymetics?
The stock symbol or ticker of Mymetics is MYMX.
Which industry does the Mymetics company belong to?
The Mymetics industry is Biotechnology.
How many shares does Mymetics have in circulation?
The max supply of Mymetics shares is 151.9K.
What is Mymetics Price to Earnings Ratio (PE Ratio)?
Mymetics PE Ratio is now.
What was Mymetics earnings per share over the trailing 12 months (TTM)?
Mymetics EPS is -107.41 USD over the trailing 12 months.
Which sector does the Mymetics company belong to?
The Mymetics sector is Healthcare.